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Abstract 
Background: Sri Lanka is currently in the prevention of re-introduction phase of malaria. The engagement of the pri-
vate sector health care institutions in malaria surveillance is important. The purpose of the study was to determine the 
number of diagnostic tests carried out, the number of positive cases identified and the referral system for diagnosis in 
the private sector and to estimate the costs involved.
Methods: This prospective study of private sector laboratories within the Colombo District of Sri Lanka was carried 
out over a 6-month period in 2015. The management of registered private sector laboratories was contacted indi-
vidually and the purpose of the study was explained. A reporting format was developed and introduced for monthly 
reporting.
Results: Forty-one laboratories were eligible to be included in the study and 28 participated by reporting data on a 
monthly basis. Excluding blood bank samples and routine testing for foreign employment, malaria diagnostic tests 
were carried out on 973 individuals during the 6-month period and nine malaria cases were identified. In 2015, a total 
of 36 malaria cases were reported from Sri Lanka. Of these, 24 (67 %) were diagnosed in the Colombo District and 
50 % of them were diagnosed in private hospitals.
Conclusions: An equal number of cases were diagnosed from the private sector and government sector in the 
Colombo District in 2015. The private sector being a major contributor in the detection of imported malaria cases in 
the country should be actively engaged in the national malaria surveillance system.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Approximately, 3.2 billion people still remain at risk of 
malaria globally. In 2015, there were an estimated 214 
million cases of malaria and 438,000 deaths [1]. Many 
countries and regions worldwide have, in the past few 
years pledged to eliminate malaria, and this requires 
commitment from both government and private sectors 
[2].
Influenced by the sustained reduction in the morbid-
ity and mortality of malaria since 1999, the anti-malaria 
campaign (AMC) of Sri Lanka embarked on phased elim-
ination of malaria from the country by the end of 2014. 
The end of the 30-year-long civil conflict and a commit-
ted effort aided by funding from Global Fund to Fight 
AIDS, Tuberculosis and Malaria (GFATM) made it pos-
sible for Sri Lanka to interrupt indigenous malaria trans-
mission by October 2012 [3]. Once malaria transmission 
is interrupted, the major challenge is the prevention of 
reintroduction through strengthening of surveillance and 
management of imported malaria cases [3]. Since Octo-
ber 2012, all malaria cases reported in Sri Lanka have 
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been imported cases. Sri Lanka was certified malaria free 
on 5th September 2016.
Re-introduction of malaria remains a possibility as 
receptivity is high with a high abundance of malaria vec-
tors, presence of a non-immune population and more 
importantly, a decreasing level of interest and awareness 
among clinicians, administrators and health care provid-
ers. Referrals for investigations for malaria parasites by 
health care providers are poor as malaria is rarely consid-
ered in the differential diagnoses of fever. This is despite 
the availability of diagnostic services (quality assured 
microscopy to identify and quantify malaria parasites 
and rapid diagnostic test kits (RDTs) to detect malaria 
antigens) throughout the country. There have been unac-
ceptable delays, sometimes even up to 30 days, to diag-
nose malaria [4]. Fifteen cases of severe malaria were 
reported, some probably as a result of delayed diagnosis 
in 2013/2014. Despite this, zero malaria mortality among 
indigenous cases has been sustained in the country since 
2007 [4]. If enhanced vigilance to detect malaria cases 
is not maintained by healthcare providers, the threat of 
malaria re-establishing in the country is high.
Given its diversity and reach, the private health sector 
is an important partner for malaria surveillance. The only 
information currently available from the private sector 
on the role of the private sector in malaria surveillance is 
the number of cases detected. The percentage of malaria 
cases identified in the private sector has increased over 
the past few years (10/47 in 2014, and 12/36 in 2015). 
The purpose of the study was to determine the number 
of diagnostic tests carried out, the number of positive 
cases identified and the referral system for diagnosis in 
the private sector and to estimate the costs involved. This 
information can be used for evidence-based decision 
making to harness the human and financial resources of 




This descriptive prospective study was carried out in 
registered private hospitals and laboratories within the 
Colombo District of the Western Province of Sri Lanka. 
This district was selected for several reasons: (a) it is the 
most populous district of Sri Lanka in which the com-
mercial as well as administrative capitals of Sri Lanka are 
located [5], (b) it has the highest number of registered 
private healthcare providers in Sri Lanka [6] and (c) the 
number of reported imported malaria cases in Western 
Province, a traditionally non-endemic area for malaria, 
has increased over the past few years (2013: 63/95, 
68.4  %; 2014: 34/49, 69.4  %; 2015: 26/36; 72.2  %) (Per-
sonal communication, Director, National Anti Malaria 
Campaign, Sri Lanka, 2016). In 2015, the highest num-
ber of malaria positives, all imported malaria cases, was 
reported from the Colombo District (24/36, 66 %). Most 
tourists visiting the country (and locals returning from 
abroad) would enter or pass through Colombo as the 
main international airport in Sri Lanka is located 40 km 
from Colombo. The Colombo District also has the larg-
est private hospitals in the country, each with a capacity 
of over 100 beds, thus attracting those seeking health-
care from other parts of the country as well as tourists 
and foreign visitors.
Malaria diagnostic services by the private sector in 
the Colombo District are provided by (a) hospitals (with 
clinic and in-patient facilities) which have their own 
diagnostic services and laboratories, and (b) stand-alone 
medical laboratories, which only provide diagnostic 
services.
All private sector healthcare institutions that provide 
diagnostic laboratory services that are registered with 
the regulator (Private Health Services Regulatory Coun-
cil, Ministry of Health, Sri Lanka) within the Colombo 
District were included in the sampling frame. The inves-
tigators visited and assessed each laboratory. The non-
functioning establishments (n = 46), laboratories, which 
do not carry out malaria diagnostic testing (n = 25) and 
specialty laboratories (e.g. reproductive health, eye care, 
n = 6) that were not likely to provide diagnostic services 
for malaria were excluded. Among the functioning labo-
ratories, information was obtained on the diagnostic test 
use and the amount that is charged from a patient.
Data collection
Following discussion with the management of the pri-
vate sector laboratories with malaria diagnostic facilities, 
permission for data collection was negotiated. Data col-
lection was done over 6  months from March to August 
2015. A format for reporting on malaria diagnostic ser-
vices was developed and pretested prior to the com-
mencement of the study. Reporting cards were given to 
each institution and collected at the end of every month. 
The monthly return included the serial number, age and 
sex of the individual undergoing a diagnostic test for 
malaria (collected from the laboratory referral note) and 
the diagnostic test used (personal details such as name 
and address were not collected). The data collection form 
also highlighted that if a malaria case is detected, the 
Anti Malaria Campaign should be immediately informed. 
Two research assistants were recruited to follow up all 
laboratories during the 6-month period. Nil reporting 
(absence of malaria cases) was adhered to by all labora-
tories after reminders were sent, first by email, and then 
by a telephone call. Several follow up calls or visits were 
sometimes required to collect the information.
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The investigators only collected data on malaria diag-
nostic tests performed and did not interfere with the 
management of a malaria patient or the subsequent 
response which was the responsibility of the respective 
hospital and the AMC.
For comparison of the number of malaria tests con-
ducted with the total number of admissions and out-
patient consultations in each of the hospitals, the hospital 
admissions registry and the out-patient department con-
sultation registries were checked with permission from 
the hospital authorities.
Data were entered and analysed using SPSS statisti-
cal software (Version 20, SPSS Inc., Chicago, IL, USA). 
Descriptive statistics were summarized and presented as 
percentages or proportions.
Results
Two hundred and five (205) private healthcare institu-
tions (hospitals with laboratory facilities and stand-alone 
laboratories) in the Colombo District were registered 
with the regulator (Private Health Services Regulatory 
Council, PHSRC). Of these, 41 laboratories were eligible 
to be included in the study (Table 1). Data were recorded 
continuously over a 6-month period from 28 laborato-
ries and the remaining 13 laboratories failed to provide 
information in spite of repeated reminders and visits 
(response rate: 68.3  %). The 28 laboratories from which 
data were collected included 13 laboratories in private 
hospitals (of which ten had performed malaria diagnostic 
tests during the study period) and 15 stand-alone private 
laboratories. Malaria diagnostic tests were performed 
only in five of the fifteen stand-alone private laboratories, 
which included three centres that screen for malaria for 
foreign employment. Malaria screening tests for foreign 
employment were counted separately. The remaining 10 
stand-alone laboratories did not receive any requests for 
diagnosis of malaria by microscopy or RDT during the 
study period.
The breakdown of the number of malaria diagnos-
tic tests carried out during the study is given in Table 2. 
Of the individuals who were investigated for malaria in 
the private sector laboratories (n  =  2046 by micros-
copy and 88 by RDTs), 951 (44.6  %) were tested due to 
requests from doctors based on clinical suspicion (863 by 
microscopy and 88 by RDTs); 8 (0.37 %) individuals got 
themselves tested by microscopy following foreign travel. 
The rest of the samples tested for malaria were routine 
testing at blood banks of these hospitals (n  =  1175, 
55.1  %). 14 blood smears were examined for malaria at 
the two stand-alone laboratories, which were all based 
on requests from General Practitioners (total malaria 
diagnostic tests based on doctors requests and self test-
ing  =  973). Eight malaria positives were reported from 
four hospital laboratories during the 6-month period 
and one malaria case was detected from one of the two 
stand-alone laboratories. All positive cases (n = 9) were 
notified to the Anti Malaria Campaign within 24  h of 
diagnosis. The diagnoses of malaria made in the private 
sector laboratories were confirmed as 100  % accurate 
on re-testing of the patient by the AMC using micros-
copy and RDT. The three private sector stand-alone 
laboratories involved in medical fitness assessment for 
foreign employment examined 12,813 blood smears for 
malaria parasites. None of blood smears were positive for 
malaria.
Of the patients diagnosed with malaria during the 
study (n-9), five were Sri Lankans who had acquired the 
disease while travelling overseas. Others were foreign 
national, two each from India and Pakistan. In the pri-
vate hospitals, five patients were diagnosed when admit-
ted with fever and three were diagnosed at out-patients 
department (OPD) consultations. Of the OPD patients, 
one had come for voluntary screening after foreign travel 
to a malaria endemic country and the others were tested 
because they presented with fever. The patient who was 
diagnosed at the stand-alone private laboratory was an 
Indian national who was referred for testing by a General 
Practitioner when he presented with fever.
During the 6 month study period, the total number of 
patients seen in the OPDs (n  =  295,325), the number 
of patients admitted to the medical wards (n =  29,515) 
and number of patients admitted to paediatric wards 
(n  =  6976) in the ten private hospitals included in the 
study was 331,816. The number of patients tested for 
malaria was 959 (0.3 %).
Rapid diagnostic tests were only available in hospitals. 
The patient cost for a RDT test in the five private hospi-
tals varied from 8.5 USD to 13.8 USD per test. The aver-
age cost was 12.1 USD. The average inpatient cost of 
Table 1 Description of  private sector laboratories 
in Colombo District
Laboratory Number (%)
Total Laboratories registered in the Colombo District 205 (100.0)
 Specialized Units 6 (2.3)
 Laboratories referring blood smears to larger centres 72 (35.1)
 Labs which do not do testing for malaria 25 (12.2)
 Closed Laboratories 46 (22.4)
 Laboratories meeting inclusion criteria 41 (20)
  Labs which sent data continuously 28
   Private hospitals 13
   Private stand alone laboratories 12
   Other Laboratories 3
  Labs which failed to send information 13
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microscopic examining of a blood smear for malaria para-
sites in the private sector was 2.5 USD; the cost of micros-
copy was cheaper by approximately 0.35 USD when 
carried out in the OPD. All laboratories used the Leish-
man method of staining of thick and thin blood smears.
Of the 2148 requests for malaria testing by the private 
hospital laboratories and stand-alone laboratories, basic 
details such as age and sex were indicated in approxi-
mately half of them (n = 1160) (Table 3).
Technical staff working at the private hospitals’ labo-
ratories covered in this study included qualified Medi-
cal Laboratory Technicians (MLT) who had completed a 
comprehensive course which includes a detailed training 
on malaria diagnosis as well. It was not possible to find 
out the qualifications of the technical personnel who 
carry out malaria diagnosis in all stand-alone laborato-
ries (as the owners of the laboratories were not keen to 
divulge this information) but 10 out of the 12 laboratories 
had a trained MLT, including the two laboratories which 
got requests.
Out of 36 malaria cases reported in Sri Lanka in 2015 
(all imported cases), twelve each were diagnosed in the 
private sector and government hospitals in the Colombo 
District (66  % of the cases in the country). Of the rest, 
two were diagnosed at government hospitals in the other 
two districts of the Western Province (Gampaha and 
Kalutara districts), and ten from the government hospi-
tals in other parts of the country (Personal communica-
tion, Director, AMC).
Discussion
Sri Lanka has been free from indigenous malaria trans-
mission since October 2012. Imported malaria infec-
tions continue to be reported in the country and steps 
are being taken to mitigate the risk of re-introduction of 
malaria [7]. A robust and responsive surveillance system 
is critical for prevention of re-introduction of malaria 
as Sri Lankan nationals travelling overseas and foreign-
ers arriving from malaria endemic countries are the key 
groups in whom imported malaria has been reported. 
Enhanced vigilance in patients presenting with fever 
with a travel history to a malaria endemic country by 
clinicians, and early diagnosis and treatment of malaria 
are critical, as delays or failure to diagnose imported 
malaria infections may considerably increase the risk for 
re-establishing local transmission [7, 8].
As in other countries, the health care needs of Sri Lan-
kans are served by both the public and the private sectors 
in parallel. Government health care services are offered 
free of charge to its citizens but its institutions are most 
often overcrowded specially in metropolitan areas such 
as Colombo. There are private healthcare providers that 
offer the same services in less congested surroundings 
which middle class Sri Lankans can afford. Foreigners, 
especially tourists, preferentially seek treatment from 
the private health sector. A similar practice is observed 
for the foreign workforce in the country (mainly Indian 
and Chinese nationals) providing labour to industrial, 
construction and agricultural projects. In general, most 
people who travel overseas, and therefore at risk of con-
tracting malaria, are those who can afford and prefer 
to access the private healthcare system when sick. It is 
estimated that the private sector contributes to 50  % of 
the total annual outpatient hospital consultations in Sri 
Lanka [9]. This, and the fact that one half of all malaria 
cases reported from the Colombo District (12/24) and 
one-third of all malaria infections reported in 2015 were 
Table 2 Number of diagnostic tests carried out for malaria from March to August 2015 in private sector institutions
a Accredited laboratories conducting malaria diagnostics as a part of routine medical examinations for employment and travel purposes
Private sector institutions (n-15) Diagnostic method
Microscopy Rapid diagnostic testing (RDT)
Hospitals (n-10) 2046 88
Stand alone diagnostic laboratories (n-2) 14
Other laboratories (n-3)a 12,813
Total 14,873 88
Table 3 Age and  sex distribution of  persons in  whom 
malaria diagnosis was requested (n = 2148)
Characteristic Number (%)
Age
 <12 29 (2.5)
 13–20 125 (10.7)
 21–30 459 (39.6)
 31–40 271 (23.3)
 41–50 161 (13.9)
 51–60 78 (6.7)
 >60 37 (3.9)
Gender
 Male 973 (82.7)
 Female 201 (17.2)
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from the private sector (12/36), points to an extremely 
important role that the private health care institutions 
play in malaria surveillance and notification. There is no 
published literature on the contribution of the private 
health care sector to malaria surveillance in Sri Lanka.
Colombo, the commercial Capital of Sri Lanka, is not 
only the most populous district in Sri Lanka (11.9  % of 
Sri Lanka’s population) with the highest population den-
sity but also has the highest number of registered private 
healthcare institutions and laboratories. Colombo is tra-
ditionally a non-endemic district for malaria. Entomo-
logical surveillance activities carried out routinely by the 
Anti Malaria Campaign have not found primary vectors 
of malaria in Colombo for decades. With the interrup-
tion of indigenous transmission, the relative proportion 
of imported malaria cases detected in Colombo and the 
Western Province has increased. Therefore, it is impor-
tant to address physician complacency and awareness of 
malaria in both government and private sector health-
care institutions in the country especially in Colombo. In 
2012, in nearly 50 % of indigenous cases and in 50 % of 
imported cases, more than 5 days had elapsed from the 
onset of fever to referral for a diagnostic test for malaria. 
Despite the widespread availability of diagnostic ser-
vices, there was a delay of more than 10 days from onset 
of fever to investigation in 26 % of locally acquired infec-
tions and 18  % of imported malaria cases [4]. In 2013, 
63  % of imported malaria cases were diagnosed with 
malaria after more than 5 days of the onset of fever and 
nearly one-third was diagnosed after more than 10 days 
of the onset of fever. In some cases more than a month 
had elapsed before the patient was investigated for 
malaria [4].
In order to improve patient referral for malaria diagno-
sis, several remedial measures are in place. One is edu-
cating doctors and laboratory staff regarding the need for 
testing for malaria in patients who are likely to have the 
disease according to the guidelines issued by the National 
Anti Malaria Campaign [10]. All healthcare institutions 
in the country including the private sector hospitals have 
received the current guidelines for testing for malaria as 
a government circular issued by the Ministry of Health, 
Sri Lanka [10]. Further, regular in-service training pro-
grammes of the Anti Malaria Campaign for the labora-
tory staff involved in diagnosis of malaria have targeted 
not only those who are in the state sector but those in the 
private sector as well.
However, as requests for laboratory investigations are 
made at the discretion of the treating physician, a direct 
one-on-one awareness raising cum advocacy programme 
may be more effective in getting guidelines into practice. 
A caveat to additional testing is the direct cost to the 
patient. Unlike in the government sector, in the private 
sector the patient has to pay for all investigations and 
doctors tend to be restrictive to the absolutely neces-
sary investigations based on their differential diagnosis to 
minimize the out-of-pocket expenditure to the patient. In 
a situation as exists in the country today, where malaria 
has been eliminated and there is absence of evidence of 
any indigenous transmission for consecutive years, the 
priority of malaria in a differential diagnosis list for an 
average patient with fever is low unless there are specific 
risk factors. This is where taking a travel history becomes 
critical. A recent history of travel to a malaria endemic 
country in a patient presenting with fever should never 
be ignored and referral for a malaria diagnostic test 
should be a must.
Only two stand-alone laboratories got requests for 
malaria testing, all from general practitioners who prob-
ably do not have their own laboratory services and there 
by have no other choice but to send their patients to a 
private sector laboratory. Overcrowded government 
hospitals also send their requests to private laboratories, 
many which have sprung up close to major government 
hospitals as the tests can be done more quickly but no 
referrals from government hospitals to private sector 
laboratories were observed in this study. The continuing 
medical education programmes conducted by the AMC 
should target general practitioners and emphasize on 
malaria awareness and expanding the coverage and fre-
quency of testing for malaria.
Despite the low referral rate for malaria diagnosis, Sri 
Lanka has been maintaining an Annual Blood Examina-
tion Rate of about 5 % during the last 5  years based on 
data provided by government health care institutions. 
The denominator of the ABER is the Sri Lankan popu-
lation and technically not the at risk population. With 
malaria elimination, it is not possible to define the at 
risk population. The ABER is maintained at 5 % through 
passive case detection, active case detection and routine 
testing of donor blood samples to blood banks through-
out the country.
With the rapid expansion of non-state run labora-
tories in Sri Lanka, it is now mandatory that all these 
institutions be registered with the regulatory author-
ity under the auspices of the Ministry of Health. As in 
the other developing countries, ascertaining the quality 
of malaria testing in the private laboratories is an enor-
mous challenge. An accreditation system for malaria 
diagnosis including the engagement of the private sec-
tor is currently being developed by the AMC. The AMC 
also provides in service training free of charge to MLTs 
from the private sector; due to most service agreements 
being contract based, it is not sure how many of these 
trained personnel will remain in active service. Though 
microscopy is the gold standard and cheaper option for 
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diagnosing malaria, RDTs offer a quick and easy way of 
making a diagnosis on the spot and may be more user-
friendly for doctors, especially for general practitioners. 
A previous study, conducted in government institutions 
when malaria was endemic and when RDTs had just 
appeared in the market, reported that the costs of per-
forming a RDT and per case detected were approximately 
14 and 20 times more than those of blood smear exami-
nation, respectively [11]. The difference in the prices in 
the private sector in this study is much less. As there is 
a price variation among the RDT kits available in dif-
ferent private hospitals, the possibility of regulating the 
price through a government assisted mechanism for the 
import of quality assured RDTs may be considered as 
an investment in sustaining the malaria free status in Sri 
Lanka by prevention of reintroduction.
AMC works in close liaison with the private sector. 
There is a dedicated focal point with a 24-h hotline to 
which any suspected or confirmed malaria case can be 
reported. Surveillance staff at the AMC headquarters has 
initiated a strong rapport with the private sector. AMC 
provides diagnostic services for immediate confirmation 
and provides free treatment as per national treatment 
guidelines to all malaria patients in the private sector. 
Essential anti malarial drugs such as artemisinin com-
bination therapy and drugs for the treatment of severe 
malaria are only available with the AMC as the avail-
ability and sale of these drugs in the market is controlled. 
This not only ensures that WHO pre-qualified drugs are 
used to treat malaria in Sri Lanka, but also warrants that 
all diagnosed cases are notified to the AMC to obtain 
treatment. Real time reporting of malaria including nil-
reporting from the private sector is now being initiated 
by the AMC using the same formats used for this study. 
Engaging the private health sector in a routine malaria 
surveillance system is a challenge encountered by the 
national programmes that have embarked on malaria 
elimination. Sri Lanka, having eliminated the disease 
since October 2012, has been making progress in engag-
ing the private health care facilities for further strength-
ening of malaria surveillance.
Limitations
This study was restricted to one district in the country. 
However, this district is the most populous in Sri Lanka 
that has the largest number of private health care insti-
tutions and reported the highest number of imported 
malaria cases in Sri Lanka since interruption of locally 
transmitted disease. The findings may have been different 
if other districts were also included. The overall response 
rate of eligible private sector laboratories was 68 %. Even 
though the response rate was less than what we expected, 
the laboratories of all the bigger private sector hospitals 
in the district, which are most likely to be visited by 
malaria patients, participated in the study. Repeated 
reminders and visits to hospitals and laboratories by 
the research team would probably have contributed to 
the response rate. Formal arrangements will have to be 
made to obtain regular feedback from private health care 
providers if the AMC engages them in the malaria sur-
veillance system. The reasons for testing (or not testing) 
patients for malaria were not investigated from a physi-
cian’s point of view.
Conclusions
Private sector hospitals and laboratories in the Colombo 
District have diagnosed one-third of all malaria cases 
reported nationwide in Sri Lanka in 2015. Engagement of 
the private sector in malaria surveillance will be critical 
for an effective national surveillance system for capturing 
of all malaria cases and timely treatment and response. 
Quality assurance of private sector malaria diagnostic 
services and reporting practices would be vital for pre-
vention of re-introduction of malaria to Sri Lanka.
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